loader
Please Wait
Applying Filters...

Information, Expiry & Status of Health Canada Patents covering Alogliptin Benzoate.

Menu
$ API Ref.Price (USD/KG) : 2,166Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Smart & Biggar

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

Alogliptin Benzoate

Brand Name : NESINA

Patent Number : 2559302

Filing Date : 2004-12-15

Strength per Unit : 6.25 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-12-15

Date Granted : 2012-06-19

blank

02

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

Alogliptin Benzoate

Brand Name : NESINA

Patent Number : 2622608

Filing Date : 2006-09-13

Strength per Unit : 6.25 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-09-13

Date Granted : 2014-08-19

blank

03

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

Alogliptin Benzoate

Brand Name : NESINA

Patent Number : 2677193

Filing Date : 2008-01-30

Strength per Unit : 6.25 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-01-30

Date Granted : 2015-06-30

blank

04

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

Alogliptin Benzoate

Brand Name : NESINA

Patent Number : 2559302

Filing Date : 2004-12-15

Strength per Unit : 12.5 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-12-15

Date Granted : 2012-06-19

blank

05

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

Alogliptin Benzoate

Brand Name : NESINA

Patent Number : 2622608

Filing Date : 2006-09-13

Strength per Unit : 12.5 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-09-13

Date Granted : 2014-08-19

blank

06

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

Alogliptin Benzoate

Brand Name : NESINA

Patent Number : 2677193

Filing Date : 2008-01-30

Strength per Unit : 12.5 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-01-30

Date Granted : 2015-06-30

blank

07

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

Alogliptin Benzoate

Brand Name : NESINA

Patent Number : 2559302

Filing Date : 2004-12-15

Strength per Unit : 25 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2024-12-15

Date Granted : 2012-06-19

blank

08

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

Alogliptin Benzoate

Brand Name : NESINA

Patent Number : 2622608

Filing Date : 2006-09-13

Strength per Unit : 25 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-09-13

Date Granted : 2014-08-19

blank

09

arrow
FNCE 2024
Not Confirmed
arrow
FNCE 2024
Not Confirmed

Alogliptin Benzoate

Brand Name : NESINA

Patent Number : 2677193

Filing Date : 2008-01-30

Strength per Unit : 25 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2028-01-30

Date Granted : 2015-06-30

blank